Prevalence, Risk Factors, and Treatment Outcomes of Isoniazid- and Rifampicin- Mono-Resistant Pulmonary Tuberculosis in Lima, Peru-Reference-Cited by-同舟云学术

Prevalence, Risk Factors, and Treatment Outcomes of Isoniazid- and Rifampicin- Mono-Resistant Pulmonary Tuberculosis in Lima, Peru

Published:2016-04-05 Issue:4 Volume:11 Page:e0152933
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Villegas Leonela,Otero Larissa,Sterling Timothy R.,Huaman Moises A.,Van der Stuyft Patrick,Gotuzzo Eduardo,Seas Carlos

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference28 articles.

1. Rifampicin mono-resistant tuberculosis in France: a 2005–2010 retrospective cohort analysis;V Meyssonnier;BMC Infect Dis,2014

2. Clinical Characteristics and Treatment Outcomes of Isoniazid Mono-Resistant Tuberculosis;A Cattamanchi;Clin Infect Dis,2009

3. Isoniazid-Monoresistant Tuberculosis in the United States, 1993 to 2003;AJ Hoopes;Arch Intern Med,2008

4. Clinical Characteristics and Treatment Outcomes of Patients with Low- and High-Concentration Isoniazid-Monoresistant Tuberculosis;T-Y Wang;PLoS ONE,2014

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Characterization of isoniazid resistance and genetic mutations in isoniazid-resistant and rifampicin-susceptible Mycobacterium tuberculosis in China;Infectious Medicine;2024-09

2. TREATMENT OUTCOME OF TUBERCULOSIS CASES AMONG PAEDIATRIC PATIENTS IN WESTERN RAJASTHAN;International Journal of Current Pharmaceutical Research;2024-07-15

3. Drug-resistant tuberculosis: a persistent global health concern;Nature Reviews Microbiology;2024-03-22

4. Prevalence of Rifampicin resistance tuberculosis among presumptive tuberculosis patients in Egypt-2021: a national health facility-based survey;BMC Infectious Diseases;2024-02-15

5. Isoniazid Monoresistance and Antituberculosis Treatment Outcome in Persons With Pulmonary Tuberculosis in Brazil;Open Forum Infectious Diseases;2024-01